iMeds.se

Atropin Stragen

Information för alternativet: Atropin Stragen 0,2 Mg/Ml Injektionsvätska, Lösning, Förfylld Spruta, visa andra alternativ
Document: Atropin Stragen 0.2 mg per ml solution for injection, prefilled syringe ENG PL change

Package leaflet: Information for the user


Atropin Stragen 0.2 mg/ml solution for injection in prefilled syringe


Atropine sulphate


Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

(Please note this medicine is mainly used in emergency situations and the doctor will have decided that you need it. It is unlikely therefore, that you will have read this leaflet before the medicine was administered to you.)



What is in this leaflet:

1. What Atropin Stragen is and what it is used for

2. What you need to know before you are given Atropin Stragen

3. How Atropin Stragen is given to you

4. Possible side effects

How to store Atropin Stragen

6. Contents of the pack and other information


1. What Atropin Stragen is and what it is used for

Atropin Stragen is one of a group of medicines called anticholinergics. Atropine sulphate, the active substance contained in Atropin Stragen, temporarily blocks some nerve endings. This decreases glands secreting, makes some muscles (such as in the gut) relax and speeds up the heart.


Atropin Stragen is used :


What you need to know before you use Atropin Stragen


You must not be given Atropin Stragen

- if you are allergic to atropine sulphate or any of the other ingredients of this medicine (listed in section 6),

- if you have trouble passing urine (e.g. if you are a man and you have an enlarged prostate),

- if you have paralysis of the bowel,

- if you suffer from severe inflammation of the colon (ulcerative colitis) or blockage in the intestines,

These contraindications do not apply in the event of life-threatening emergencies.


Warnings and precautions

Talk to your doctor or nurse before you are given Atropin Stragen if you have any of the following:


Elderly patients and other special populations

Atropin Stragen should be used with caution in elderly patients as they are more sensitive to the effects of the product and are more likely to experience side effects. Atropin Stragen should also be used with caution in patients suffering from Down syndrome because its effect may be stronger. It should also be used with caution in patients suffering from albinism because its effect may be weaker.


Note: Atropin Stragen will make you sweat less and you may overheat.


Other medicines and Atropin Stragen

Tell your doctor if you are taking, have recently taken or might take any other medicines.


Some medicines may enhance the effect of Atropin Stragen. These include:


Atropin Stragen may impair the effect of the following medicines:


Atropin Stragen delays gastric emptying and may therefore alter the effect of other medicines.


Pregnancy and breast-feeding

Please inform your doctor or nurse before being given this injection if you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby. The doctor will then decide if this injection is suitable for you.


Driving and using machines

Because of your complaint being treated you will probably not feel well enough to drive or use machinery. However, consult your doctor before considering driving a car or using machinery as Atropin Stragenmay cause drowsiness and blurred vision.


Atropin Stragen contains sodium

This medicinal product contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium- free’.


How Atropin Stragen is given to you


Atropin Stragen will be given to you as an injection by a doctor or a specially trained nurse.The injection may be given into a muscle or directly into the blood stream (into a vein).


Your doctor will decide what dose is right for you and this will depend on what it is being used to treat. Your dose may be calculated according to your weight.


What to do if you have been given more Atropin Stragenthan you should

This is unlikely because the dose will be administered by a doctor or nurse who will be experienced in its use. The doses of Atropin Stragen will be carefully worked out, especially for elderly, because they are more sensitive to it. If you suspect that you have been given too much, you should tell the doctor or nurse immediately.


The prefilled syringe is not adapted to administration in the paediatric population; the graduation does not permit accurate measurement.


If you have any further questions on the use of this product, ask your doctor or nurse.


4. Possible side effects


Like all medicines, this medicine can cause side effects, although not everybody gets them.


The side effects depend on the dose you are given and usually disappear when the treatment is discontinued.


Rarely an allergic reaction may develop. This may cause skin rashes, severe itching, peeling of the skin, swelling of the face (especially around the lips and eyes), tightening of the throat and difficulty breathing or swallowing, fever, dehydration, shock and fainting. These are all very serious side effects. Tell your doctor immediately if you experience any of these side effects. You may need urgent medical attention.


Very common side effects (may affect more than 1 in 10 people)


Common side effects (may affect up to 1 in 10 people)


Uncommon side effects (may affect up to 1 in 100 people)

psychotic reactions.


Rare side effects (may affect up to 1 in 1,000 people)


Very rare side effects (may affect up to 1 in 10,000 people)


Not known (frequency cannot be estimated from the available data)


Reporting of side effects

If you get any side effects, talk to your doctor or nurse.This includes any possible side effects not listed in this leaflet.You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.


5. How to store AtropinStragen


This medicinal product does not require any special storage conditions.


Keep this medicine out of the sight and reach of children.


Do not use this medicine after the expiry date which is stated on the carton, the syringe and the blister after EXP. The expiry date refers to the last day of that month.


Do not throw away any medicines via wastewater or household waste. These measures will help protect the environment.

The medical personnel will dispose of the syringe and any medicine no longer needed according to the local requirements.


6. Contents of the pack and other information


What Atropin Stragen contains


The active substance is atropine sulphate.

Each ml of solution for injection contains 0.2 mg atropine sulphate. Each 5 ml pre-filled syringe contains 1 mg atropine sulphate.


The other ingredients are: sodium chloride, concentrated hydrochloric acid (for pH adjustment), water for injections (See section 2 ”Atropin Stragencontains sodium”).


What Atropin Stragen looks like and contents of the pack


Atropin Stragen is a clear and colourless solution for injection in a 5 ml polypropylene pre-filled syringe with a polypropylene tip cap, sterile outer surface; individually packaged in a transparent blister pack; in box of 10.


Marketing Authorisation Holder


<[To be completed nationally]>


Manufacturer


<[To be completed nationally]>


This leaflet was last revised in


31 March 2016


-----------------------------------------------------------------------------------------------------------------------------

The following information is intended for healthcare professionals only:


Instructions for use:

Be careful to strictly respect the protocol for the use of the syringe.

The pre-filled syringe is for single patient only. Discard syringe after use. DO NOT REUSE.

The content of un-opened and un-damaged blister is sterile, and must not be opened until used.

The product should be inspected visually for particles and discoloration prior to administration. Only clear colourless solution free from particles or precipitates should be used.

The product should not be used if the tamper evident seal on syringe is broken.

The prefilled syringe is not adapted to administration in the paediatric population; the graduation does not permit accurate measurement.


Using aseptic technique, Atropin Stragen 0.2 mg/ml, Solution for injection in pre-filled syringe can be used on a sterile field.





1. Before opening the syringe, push firmly the piston rod in order to break open the syringe plunger.



2. Twist off the tip cap to break the frangible obturator.





3. Check that the sealing cap has been completely removed.



4. Purge the air of the syringe by pushing the piston slightly.


5. Connect the syringe to the IV access.

Push the piston carefully to inject the required volume.



Any unused product or waste material should be disposed of in accordance with local requirements.

This medicinal product must not be mixed with other medicinal products.


6